| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |